Jean‐Paul Pirnay

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

P. Jault, Thomas Leclerc, Serge Jennes et al. · The Lancet Infectious Diseases · 2018 · 843 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

Maya Merabishvili, Jean‐Paul Pirnay, Gilbert Verbeken et al. · PLoS ONE · 2009 · 506 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens

Yves Briers, Maarten Walmagh, Victor Van Puyenbroeck et al. · mBio · 2014 · 406 citations · Full text

Life Sciences, Biotechnology, Microbiology +17

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs et al. · Nature Microbiology · 2024 · 389 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Pseudomonas aeruginosa Population Structure Revisited

Jean‐Paul Pirnay, Florence Bilocq, Bruno Pot et al. · PLoS ONE · 2009 · 296 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17